Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Durvalumab
Colorectal Cancer
Gruppo Oncologico del Nord-OvestP2B (61)
Durvalumab
Metastatic Malignant Neoplasm In The Colon
University of IowaP2B (61)
Durvalumab
Esophageal Adenocarcinoma
University of California, IrvineP2B (61)
Durvalumab
Head And Neck Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP2B (61)
Durvalumab
Melanoma
AstraZenecaP2B (61)
Durvalumab
Pancreatic Ductal Adenocarcinoma
Jonsson Comprehensive Cancer CenterP2B (61)
Durvalumab
Prostate Cancer
OHSU Knight Cancer InstituteP2B (61)
Durvalumab
Triple-Negative Breast Carcinoma
Queen Mary University of LondonP2B (61)
Emraclidine
Schizophrenia
AbbVieP2B (61)
Encorafenib
Cutaneous Melanoma
University of UtahP2B (61)
Encorafenib
Colorectal Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP2B (61)
Encorafenib
Rectum Adenocarcinoma
National Cancer Institute (NCI)P2B (61)
Epirubicin
Sarcoma
EpkinP2B (61)
Eribulin
Her2-Receptor Negative Breast Cancer
Sun Yat-sen UniversityP2B (61)
Etoposide
Neoplastic Meningitis
Guangzhou Medical UniversityP2B (61)
EUDEMINE INJECTION
Hyperinsulinism
Columbia UniversityP2B (61)
Everolimus
Epilepsy
Xuanwu Hospital, BeijingP2B (61)
Everolimus
Glioblastoma
Nationwide Children's HospitalP2B (61)
Famitinib
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (61)
Fludarabine
Acute Myeloid Leukemia By FAB Classification
City of Hope Medical CenterP2B (61)
Fludarabine
Cancer
National Cancer Institute (NCI)P2B (61)
Fludarabine
Colorectal Cancer
University of PennsylvaniaP2B (61)
Fludarabine
Myelodysplastic Syndrome With Excess Blasts-1
Masonic Cancer Center, University of MinnesotaP2B (61)
Fludarabine
Neoplasm
National Cancer Institute (NCI)P2B (61)
FLUDEOXYGLUCOSE
Rectal Cancer
National Cancer Institute (NCI)P2B (61)
Showing 1401 to 1425 of 13,155 assets
PreviousPage 57 of 527Next